HomeAboutRankingsData Sources
© 2026 GeneE
🧬
GeneE
10 sources retrieved · Most recent: April 2026 · Index updated 15 days ago
ⓘGeneE is for informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
SCAMP3
secretory carrier membrane protein 3
Chromosome 1 · 1q22
NCBI Gene: 10067Ensembl: ENSG00000116521.12HGNC: HGNC:10565UniProt: A0AAQ5BHM9
135PubMed Papers
20Diseases
0Drugs
0Pathogenic Variants
FUNCTIONAL ROLE
Transporter
DATA QUALITY
✓ Experimental GO Evidence✓ Swiss-Prot Reviewed
ubiquitin protein ligase bindingextracellular exosometrans-Golgi network membranerecycling endosome membraneCrohn's diseaseDecreased total leukocyte countrisk-taking behaviourneutropenia
✦AI Summary

SCAMP3 (secretory carrier membrane protein 3) is a transmembrane recycling carrier that regulates post-Golgi trafficking and endosomal-lysosomal pathways 1. Mechanistically, SCAMP3 localizes to early endosomes and recycling endosomes, where it negatively regulates epidermal growth factor receptor (EGFR) degradation by interacting with ubiquitin ligases (Nedd4) and ESCRT machinery (Tsg101, Hrs) through its PY and PSAP motifs, thereby promoting receptor recycling to the cell surface 1. SCAMP3 also participates in pathogen-induced membrane trafficking, forming Salmonella-induced tubular networks during bacterial infection 2. SCAMP3 expression is regulated by a feed-forward loop involving miR-27a/b-3p and PPARG during adipogenesis, where SCAMP3 exhibits anti-adipogenic functions and correlates with insulin resistance 3. Disease relevance varies by context: in lung adenocarcinoma, SCAMP3 functions as a tumor suppressor by promoting EGFR degradation and attenuating MAP kinase signaling 4, while in breast cancer and prostate cancer, SCAMP3 promotes oncogenic progression through EGFR stabilization, ERK signaling, and stemness pathways 567. High SCAMP3 expression in breast cancer correlates with poor prognosis, chemoresistance, and reduced survival 5. These divergent roles suggest SCAMP3 context-dependently influences cancer progression and therapeutic resistance.

Sources cited
1
SCAMP3 localizes to early endosomes, negatively regulates EGFR degradation through ubiquitylation and ESCRT interactions, and promotes receptor recycling
PMID: 19158374
2
SCAMP3 forms Salmonella-induced tubular networks distinct from other membrane structures during bacterial infection
PMID: 21353564
3
miR-27a/b-3p and PPARG regulate SCAMP3 in a feed-forward loop; SCAMP3 suppression promotes adipogenesis and is associated with insulin resistance
PMID: 31554889
4
SCAMP3 is a tumor suppressor in lung adenocarcinoma; phosphorylation at Y86 by mutant EGFR increases EGFR interaction and promotes receptor degradation
PMID: 33850265
5
SCAMP3 promotes breast cancer progression through c-MYC-β-Catenin-SQSTM1 axis; high expression correlates with poor prognosis and chemoresistance
PMID: 36627007
6
SCAMP3 and EPS8 cooperatively regulate EGFR stability and signaling to promote enzalutamide resistance in prostate cancer
PMID: 41151858
7
SCAMP3 coordinates ERK1/2 signaling and autophagy in triple-negative breast cancer; SCAMP3 loss impairs mTORC1 signaling and autophagic flux
PMID: 41096842
8
SCAMP3 is identified as a protein interactor in the context of viral protein degradation and host cell defense mechanisms
PMID: 39128851
Disease Associationsⓘ20
Crohn's diseaseOpen Targets
0.17Weak
Decreased total leukocyte countOpen Targets
0.17Weak
risk-taking behaviourOpen Targets
0.15Weak
neutropeniaOpen Targets
0.15Weak
gastric carcinomaOpen Targets
0.13Weak
atrial fibrillationOpen Targets
0.12Weak
goutOpen Targets
0.12Weak
hepatocellular carcinomaOpen Targets
0.10Weak
neoplasmOpen Targets
0.10Weak
type 2 diabetes mellitusOpen Targets
0.09Suggestive
gliomaOpen Targets
0.08Suggestive
lung adenocarcinomaOpen Targets
0.07Suggestive
prostate cancerOpen Targets
0.07Suggestive
triple-negative breast cancerOpen Targets
0.07Suggestive
breast cancerOpen Targets
0.03Suggestive
infectionOpen Targets
0.03Suggestive
diabetes mellitusOpen Targets
0.03Suggestive
COVID-19Open Targets
0.03Suggestive
Alzheimer diseaseOpen Targets
0.03Suggestive
HirsutismOpen Targets
0.02Suggestive
Pathogenic Variants
No pathogenic variants reported on ClinVar for this gene.
View on ClinVar ↗
Related Genes
SCAMP2Shared pathway100%SCAMP1Shared pathway75%SCAMP4Shared pathway67%ZG16Shared pathway33%SYCNShared pathway33%EXOC3L1Shared pathway33%
Tissue Expression6 tissues
Heart
100%
Lung
86%
Liver
83%
Brain
72%
Ovary
64%
Bone Marrow
55%
Gene Interaction Network
Click a node to explore
SCAMP3SCAMP2SCAMP1SCAMP4ZG16SYCNEXOC3L1
PROTEIN STRUCTURE
Preparing viewer…
AlphaFoldAI-predicted · UniProt O14828
View on AlphaFold ↗
Constraintⓘ
LOEUFⓘ
0.88LoF Tolerant
pLIⓘ
0.00Tolerant
Observed/Expected LoF0.65 [0.49–0.88]
RankingsWhere SCAMP3 stands among ~20K protein-coding genes
  • #3,435of 20,598
    Most Researched135 · top quartile
  • #7,861of 17,882
    Most Constrained (LOEUF)0.88
Genes detectedSCAMP3
Sources retrieved10 papers
Response time—
📄 Sources
10▼
1
Salmonella-induced tubular networks.
PMID: 21353564
Trends Microbiol · 2011
1.00
2
AP3B1 facilitates PDIA3/ERP57 function to regulate rabies virus glycoprotein selective degradation and viral entry.
PMID: 39128851
Autophagy · 2024
0.90
3
MicroRNA-27a/b-3p and PPARG regulate SCAMP3 through a feed-forward loop during adipogenesis.
PMID: 31554889
Sci Rep · 2019
0.80
4
SCAMP3 promotes breast cancer progression through the c-MYC-β-Catenin-SQSTM1 growth and stemness axis.
PMID: 36627007
Cell Signal · 2023
0.70
5
SCAMP3 and EPS8 Cooperatively Regulate EGFR Signaling to Promote Enzalutamide Resistance and Metastatic Potential in Prostate Cancer.
PMID: 41151858
Cancer Genomics Proteomics · 2025
0.60